openPR Logo
Press release

Global Phosphodiesterase (PDE) Inhibitors Market 2021 Analysis May Set New Growth Story, Forecast to 2027

01-17-2022 02:04 PM CET | Health & Medicine

Press release from: Orion Market Research

The global phosphodiesterase (PDE) inhibitors market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The PDE is found in the cytosol, plasma membranes, endoplasmic reticulum, nuclear membranes, and cytoskeleton. Majorly, the two types of PDE inhibitors including the selective and non-selective are being discovered as possible treatments for various indications, such as chronic obstructive pulmonary disease (COPD), Alzheimer’s disease, and other ailments. Thus, such novel application of these inhibitors in the treatment of various diseases is promising a strong market growth during the forecast period. Another pivotal factor that is driving the global PDE inhibitors market growth includes the rise in the prevalence of erectile dysfunction disorder. According to the World Health Organization, about 150 million people have been affected by erectile dysfunction across the globe and the number is projected to reach 230 million by 2025. It is a common medical condition affecting about 15% of men each year.

To Request a Sample of our Report on Global Phosphodiesterase (PDE) Inhibitors Market: https://www.omrglobal.com/request-sample/phosphodiesterase-pde-inhibitors-market

Some key players operating in the market include Bayer AG, Eli Lilly and Co., GlaxoSmithKline Plc, and Pfizer Inc., among others. These players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in July 2018, Adamis Pharmaceuticals Corp. (Adamis) announced that it has been conducting pre-IND development work for a fast-dissolving sublingual tablet containing tadalafil, which is a drug used to treat erectile dysfunction. Further, in September 2020, Aspargo Laboratories, Inc. acquired the international rights to Sildenafil oral spray for the treatment of erectile dysfunction.

Market Coverage

· The market number available for – 2020-2027

· Base year- 2020

· Forecast period- 2021-2027

· Segment Covered

· Regions Covered- Globally

· Competitive Landscape: Bayer AG, Eli Lilly and Co., GlaxoSmithKline Plc, and Pfizer Inc., among others.

(Get 15% Discount on Buying this Report)

A full Report of Global Phosphodiesterase (PDE) Inhibitors Market is Available at: https://www.omrglobal.com/industry-reports/phosphodiesterase-pde-inhibitors-market

Global Phosphodiesterase (PDE) Inhibitors Market by Segmentation

By Type

• Selective PDE Inhibitors

· PDE-1

· PDE-2

· PDE-3

· PDE-4

· PDE-5

· Others

• Non-Selective PDE Inhibitors

By Route of Administration

• Oral

• Topical

• Others

By Application

• CVD

• Erectile Dysfunction

• Pulmonary Hypertension

• Respiratory Disease

• Benign Prostate Hyperplasia

• Others

Global Phosphodiesterase (PDE) Inhibitors Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Phosphodiesterase (PDE) Inhibitors Market 2021 Analysis May Set New Growth Story, Forecast to 2027 here

News-ID: 2529229 • Views: 165

More Releases from Orion Market Research

Asia-Pacific Alcoholic Beverages Market Size, Share, Analysis, Industry Report a …
Asia-Pacific alcoholic beverages market is estimated to grow at a CAGR of 3.6% during the forecast period. In 2018, the market in Asia-Pacific was valued at $331.6 billion and is further estimated to reach $420.0 billion in 2025. The factors contributing to the market growth include increasing demand for alcoholic beverages in emerging economies such as China and India due to their huge population base, growing consumption of alcohol by
Cardiac Holter Monitor Market Trends, Research Report, Growth, Opportunities, Fo …
The global cardiac holter monitor market is anticipated to grow at a considerable CAGR of 7.0% during the forecast period (2022-2028). The global cardiac holter monitor market is led by the significant shift toward miniaturization of diagnostic tools and preventive healthcare devices among individuals. Traditional ECG monitoring devices are often inconvenient to carry as they has many electrodes to attach to the chest, and also involved in high-power consumption. These
Bariatric Surgery Market Share 2022: Trends, Key Players, Industry Analysis and …
The global bariatric surgery market is anticipated to grow at a considerable CAGR of 9.2% during the forecast period (2022-2028). Due to recent advances in weight loss surgery or bariatric surgery, there has been a significant improvement in the reliability of procedures. Technological advancements in bariatric surgical devices is one of the major contributor adding to the growth of global bariatric surgery market. Frequent upgradation to newer technology allows the
Adult Toothbrush Market Trends, Business Overview, Industry Growth and Forecast …
The global adult toothbrush market is anticipated to grow at a CAGR of 5.0% during the forecast period (2022-2028). Adult toothbrush as the names suggest are the widely used household personal care items that primarily supports in maintaining optimum oral hygiene. The market growth is majorly attributable to the growing awareness among global population towards upkeeping the oral hygiene. This is further coupled with the growing cases of tooth decay and

All 5 Releases


More Releases for PDE

05-19-2021 | Health & Medicine
Freyr
Freyr Completes 1500+ PDE Reports in Three (3) Years
Freyr, a leading global Regulatory solutions and services provider, is pleased to announce the feat of completing 1500+ Permissible Daily Exposure (PDE) reports. The feat has been achieved within three (3) years of the implementation of the European Medicines Agency’s (EMA’s) ‘Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/ SWP/169430/2012) across the globe for all the
PDE 1 Inhibitor Market Opportunity Assessment and Research Analysis 2020 | Taked …
PDE 1 Inhibitor -Pipeline Insight, 2020 The global PDE 1 Inhibitor Market research report 2020 provides a basic overview of the industry including definitions, classifications, applications, and industry chain structure. The PDE 1 Inhibitor market report provides information regarding market size, share, trends, growth, cost structure, global market competition landscape, market drivers, challenges and opportunity, capacity, revenue, and forecast. The report delivers a comprehensive overview of the crucial elements of the market
Global PDE Inhibitors Market Research Report 2015-2025
About the Global PDE Inhibitors Market Research Report 2015-2025: Global PDE Inhibitors Market Research Report 2015-2025 is divided into various key segments like device type, material, applications, and end users. The report is thoroughly analyzed and studied by the researchers to offer deep insights on each of these segments with statistics. This information is beneficial for the manufacturers in the industry to plan their policies and strategies accordingly and gain topmost
Global PDE Inhibitors Market Capacity, Production, Value, Consumption, Status an …
visionresearchreports.com adds “Global PDE Inhibitors Market Research Report 2018” new report to its research database. This report studies the global PDE Inhibitors market status and forecast, categorizes the global PDE Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Hanmi Science Holding Boehringer Ingelheim Takeda Pharmaceuticals Pfizer Omeros Anacor
PDE Inhibitor Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-other-reports/pde-inhibitor-market/71843 The global market size of PDE Inhibitor is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand,
Phosphodiesterase Enzyme (PDE) Inhibitors Market Opportunity Analysis, 2018-2026
Phosphodiesterase are a diverse family of enzymes (11 isoenzymes) that play a key role in regulating intracellular levels of secondary messengers - cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate. These enzymes identified to be pharmacologically active in the 1950s, hydrolyses cyclic nucleotides to treat various diseases such as cardiovascular, respiratory and erectile dysfunction. Distinct distribution of all the types of isoenzymes has provided possibilities for selective target therapies. Request a